A Prospective Analysis To Assess The Potential Use Of ECGio In Clinical Practice

Condition(s) studied

Investigational drug(s) / intervention(s)

AI-Assistive Algorithm: ECGio is the first coronary stenosis detection software utilizing data from just a 10-second electrocardiogram (ECG). ECGs are inexpensive, non-invasive, commonly administered tests, and measure the electrical activity of the heart in "waves". The ECGio diagnostic algorithm is an ECG analytic tool which provides the clinician with information to detect the presence, severity, and location of clinically significant coronary artery disease. This diagnostic algorithm is currently not FDA approved, but once FDA approval is received, the labeling will address the following indication and use.

Study summary

The goal of this observational study is to learn if an ai-assistive algorithm would be useful in patients who are under suspicion of coronary disease. The main question it aims to answer:

What proportion of patients would clinicians see fit to order an ai-assistive algorithm if available for clinical use?

Participants will be asked to use clinical judgement as to whether a patient fits a predetermined criteria for use and select them for ai-assistive analysis.

Eligibility

Primary outcome measure(s)

• Usage Proportion — During or within 1 day, on average, of the patient visit
  The proportion of patients in which it was deemed appropriate to use the AI-Assistive Algorithm

Trial sites (4)

More Heart Input Output Inc trials in the USA